Read + Share
Amedeo Smart
Independent Medical Education
Prelaj A, Bottiglieri A, Proto C, Lo Russo G, et al. Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program. Eur J Cancer 2021;149:235-248.PMID: 33820681
Email
LinkedIn
Facebook
Twitter
Privacy Policy